AI assistant
Sending…
GENTEX CORP — Director's Dealing 2021
Oct 25, 2021
30893_dirs_2021-10-25_81729f55-c985-4ae2-8157-c2d7f3004ccf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-10-25
Reporting Person: Ryan Scott P (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-25 | Common Stock | M | 4580.00 | $16.01 | Acquired | 35789.00 | Direct |
| 2021-10-25 | Common Stock | S | 9224.00 | $34.27 | Disposed | 26565.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-25 | Employee Stock Option (Right to Buy) | $16.01 | M | 4580.00 | Disposed | 2022-12-31 | Common Stock (4580.00) | Direct |
Footnotes
F1: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan.
F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F3: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19